Identification of a <i>TPP1</i> Q278X Mutation in an Iranian Patient with Neuronal Ceroid Lipofuscinosis 2: Literature Review and Mutations Update
Neuronal ceroid lipofuscinoses type 2 (CLN2), the most common form of Batten disease, is caused by TPP1 loss of function, resulting in tripeptidyl peptidase-1 enzyme deficiency and cerebral accumulation of lipopigments. Clinical hallmarks include epileptic seizures, vision loss, progressive movement...
Main Authors: | Tayebeh Baranzehi, Dor Mohammad Kordi-Tamandani, Maryam Najafi, Ali Khajeh, Miriam Schmidts |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/21/6415 |
Similar Items
-
Generation of pathogenic TPP1 mutations in human stem cells as a model for neuronal ceroid lipofuscinosis type 2 disease
by: Li Ma, et al.
Published: (2021-05-01) -
Modelling of Neuronal Ceroid Lipofuscinosis Type 2 in <i>Dictyostelium discoideum</i> Suggests That Cytopathological Outcomes Result from Altered TOR Signalling
by: Paige K. Smith, et al.
Published: (2019-05-01) -
Case report: Analysis of novel compound heterozygous TPP1 variants in a Chinese patient with neuronal ceroid lipofuscinosis type 2
by: Sui-Bing Miao, et al.
Published: (2022-08-01) -
<i>CLN8</i> Mutations Presenting with a Phenotypic Continuum of Neuronal Ceroid Lipofuscinosis—Literature Review and Case Report
by: Magdalena Badura-Stronka, et al.
Published: (2021-06-01) -
A Case Report on the Challenging Diagnosis of Neuronal Ceroid Lipofuscinosis Type 2 (CLN2)
by: Andrea Nunes, et al.
Published: (2020-12-01)